J. Pedersen‐Bjergaard

D. Christiansen, M. Andersen, J. Pedersen‐Bjergaard, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia

D. Christiansen, M. Andersen, J. Pedersen‐Bjergaard, 2005, Leukemia.

Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy

D. Christiansen, J. Pedersen‐Bjergaard, 2001, Leukemia.

Blastic transformation of chronic myelocytic leukaemia. Clinical manifestations, prognostic factors and results of therapy.

J. Pedersen‐Bjergaard, B. Hainau, A. Worm, 2009, Scandinavian journal of haematology.

Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II

J. Rowley, M. L. Beau, R. Larson, 1993 .

Genetics of therapy-related myelodysplasia and acute myeloid leukemia

D. Christiansen, J. Pedersen‐Bjergaard, M. Andersen, 2008, Leukemia.

Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities

D. Christiansen, J. Pedersen‐Bjergaard, F. Skovby, 2002, Leukemia.

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

M. Andersen, J. Pedersen‐Bjergaard, C. Nerlov, 2002, Blood.

Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of man.

J. Pedersen‐Bjergaard, P. Philip, P. Andersson, 2009, Scandinavian journal of haematology.

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation.

M. Andersen, J. Pedersen‐Bjergaard, D. Christiansen, 2004, Blood.

M. Andersen, J. Pedersen‐Bjergaard, D. Christiansen, 2001, British journal of haematology.

Phase II Trial of Prednimustine®, Leo-1031 (NSC-134087) in Acute Non-Lymphocytic Leukaemia

J. Pedersen‐Bjergaard, P. J. Sørensen, M. K. Jensen, 2009 .

Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients

N. Nissen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 1984, Cancer.

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I‐II non‐hodgkin's lymphomas

N. Nissen, J. Pedersen‐Bjergaard, J. Ersbøll, 2006, Cancer.

Chronic myelocytic leukaemia presenting in blastic transformation. Two cases primarily diagnosed as acute myelocytic leukaemia.

J. Pedersen‐Bjergaard, A. Worm, 2009, Scandinavian journal of haematology.

Follicular low‐grade non‐Hodgkin's lymphoma: Long‐term outcome with or without tumor progression

N. Nissen, J. Pedersen‐Bjergaard, J. Ersbøll, 1989, European journal of haematology.

Mutation of the ms Protooncogenes and Chromosome Aberrations in Acute Nonlymphocytic Leukemia and Preleukemia Related to Therapy with Alkylating Agents 1

C. Bartram, J. Pedersen‐Bjergaard, J. Lyons, 2006 .

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.

M. Ro̸rth, S. Larsen, H. Mouridsen, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CEPHALOTHIN IN THE TREATMENT OF PENICILLIN SENSITIVE PATIENTS

J. Pedersen‐Bjergaard, 1967 .

Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.

J. Rowley, R. Larson, M. L. Le Beau, 1993, Blood.

THE CLINICAL DIAGNOSIS OF PENICILLIN ALLERGY

J. Pedersen‐Bjergaard, 1970, Acta allergologica.

POSSIBLE ADVANTAGES OF HIGHLY PURIFIED PENICILLIN IN AVOIDING PENICILLOYL‐SPECIFIC SENSITIZATION AND ALLERGIC REACTIONS *

J. Pedersen‐Bjergaard, 1969, Acta allergologica.

SPECIFICITY FOR BENZYLPENICILLIN, PENICIELOYL COMPOUNDS, AND BENZYLPENICILLOATE IN HUMAN ALLERGY TO PENICILLIN

J. Pedersen‐Bjergaard, 1969, Acta allergologica.

SIGNIFICANCE OF THE PENICILLOYL RADICAL IN PENICILLIN ALLERGY

J. Pedersen‐Bjergaard, 1967, Acta allergologica.

Cytogenetically unrelated clones in therapy‐related myelodysplasia and acute myeloid leukemia: Experience from the Copenhagen series updated to 180 consecutive cases

M. Andersen, J. Pedersen‐Bjergaard, P. Philip, 1998, Genes, chromosomes & cancer.

SPECIFIC HYPOSENSITIZATION OF PATIENTS WITH PENICILLIN ALLERGY

J. Pedersen‐Bjergaard, 1969, Acta allergologica.

Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia.

S. Larsen, J. Pedersen‐Bjergaard, P. Philip, 1990, Blood.

Severe aplastic anaemia with complete autologous marrow reconstitution following treatment with antithymocyte globulin. Report of a case and review of the literature.

N. Nissen, J. Pedersen‐Bjergaard, P. Ernst, 2009, Scandinavian journal of haematology.

P. Möller, J. Pedersen‐Bjergaard, A. Waage, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop †

S. Jhanwar, R. Larson, S. Schnittger, 2002, Genes, chromosomes & cancer.

The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia.

J. Pedersen‐Bjergaard, P. de Nully Brown, C. Geisler, 1997, Leukemia research.

Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy‐related MDS and AML after therapy with alkylating agents: An M‐FISH study

M. Andersen, J. Pedersen‐Bjergaard, D. Christiansen, 2005, Genes, chromosomes & cancer.

Molecular Characterization of 12 p Abnormalities in Hematologic Malignancies : Deletion of K I P I , Rearrangement of TEL , and Amplification of CCND 2

P. Marynen, B. Johansson, F. Mitelman, 2002 .

D. Christiansen, M. Andersen, J. Pedersen‐Bjergaard, 2000, Blood.

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.

N Keiding, S O Larsen, N. Keiding, 1985, Annals of internal medicine.

Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulins.

A. Wiik, J. Pedersen‐Bjergaard, M. Thomsen, 2009, Scandinavian journal of haematology.

NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features

D. Christiansen, J. Pedersen‐Bjergaard, M. Andersen, 2008, Leukemia.

Cytogenetic characteristics of therapy‐related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases

J. Pedersen‐Bjergaard, P. Philip, 1987, British journal of haematology.

Defect in Acute Myeloid Leukemia with Trisomy 11 as a Recurrent Molecular ALL 1 Partial Tandem Duplication of Updated

M. Caligiuri, C. Bloomfield, C. Croce, 2006 .

BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem‐cell source and previous treatment

M. Hansen, J. Pedersen‐Bjergaard, C. Geisler, 1998, European journal of haematology.

BEAM+autologous stem cell transplant at ionk malignant lymphoma: 100 consecutive centre. Efficacy, transplants in a single toxicity and engraftment

M. Hansen, J. Pedersen‐Bjergaard, C. Geisler, 1998 .

Predictive value of bone marrow cultures in 48 patients with acute myeloblastic leukaemia or myelodysplasia both secondary to treatment of other malignant diseases.

N. Nissen, J. Pedersen‐Bjergaard, J. Ersbøll, 2009, Scandinavian journal of haematology.

Leiomyosarcoma of the urinary bladder after cyclophosphamide.

J. Pedersen‐Bjergaard, K. Hou‐Jensen, M. Pedersen, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias.

J. Pedersen‐Bjergaard, P. Philip, 1988, Cancer genetics and cytogenetics.

Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial

N. Nissen, J. Pedersen‐Bjergaard, H. Brincker, 1984, Cancer treatment reports.

Genetic Pathways in t-MDS and t-AML, a Revised Model.

M. Andersen, J. Pedersen‐Bjergaard, D. Christiansen, 2004 .

High risk of therapy‐related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5‐fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer

M. Andersson, J. Pedersen‐Bjergaard, P. Philip, 1990, Cancer.

intensive chemotherapy of small cell carcinoma of the lung Acute nonlymphocytic leukemia, preleukemia, and solid tumors following

J. Pedersen‐Bjergaard, P. Philip, K. Østerlind, 2011 .

Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung.

H. Hansen, J. Pedersen‐Bjergaard, P. Philip, 1985, Blood.

3 Therapy-related myelodysplasia

J. Pedersen‐Bjergaard, 2007 .